SCHEMBL6137342

SCHEMBL6137342

NC1=Nc2ccc(C(F)(F)F)cc2C2CCCC12F

nearest known ligand 0.69

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 7/20 0.69
NOS1 P29475 7/20 0.69
NOS2 P35228 7/20 0.69
PNMT P11086 1/20 0.38
CTSD P07339 3/20 0.35
CHRNB2 P17787 2/20 0.35
CHRNA4 P43681 2/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
KDM1A O60341 3/20 0.34
MAOA P21397 2/20 0.34
MAOB P27338 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6137347 0.83 NOS3 (0.74) NOS3NOS1NOS2MAOAMAOB
SCHEMBL6137722 0.83 NOS3 (0.74) NOS3NOS1NOS2KDM1A
SCHEMBL6137320 0.82 NOS3 (1.00) NOS3NOS1NOS2
SCHEMBL6137334 0.82 NOS3 (0.72) NOS3NOS1NOS2KDM1A
SCHEMBL6137760 0.79 NOS3 (0.67) NOS3NOS1NOS2KDM1AMAOA
SCHEMBL6137675 0.79 NOS3 (0.67) NOS3NOS1NOS2CHRNB2CHRNA4
SCHEMBL6137311 0.78 NOS1 (1.00) NOS3NOS1NOS2
SCHEMBL6137654 0.75 NOS3 (0.68) NOS3NOS1NOS2MAOAMAOB
SCHEMBL6646596 0.69 NOS1 (1.00) NOS3NOS1NOS2PNMT
SCHEMBL6137403 0.68 NOS3 (1.00) NOS3NOS1NOS2KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1129077-B9 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AG (DE) 2005-07-20 EP disclosed
EP-1129077-B1 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AG (DE) 2005-04-20 EP disclosed
US-6579883-B1 Nitrogen monoxide synthases; 4-amino-8-bromo-3a-fluoro-2,3,3a,9b-tetrahydro-1H-cyclopenta (c) quinoline; neurodegenerative, autoimmune, cardiovascular diseases SCHERING AKTIENGESELLSCHAFT (DE) 2003-06-17 US disclosed